MyAverix Finance
US · Healthcare
Virax Biolabs Group Limited Ordinary Shares (VRAX)
Biotechnology
Virax Biolabs Group Limited Ordinary Shares (VRAX) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-25, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for VRAX
Virax Biolabs Group Limited Ordinary Shares (VRAX) — FAQ
What is VRAX's P/E ratio?
The price-to-earnings (P/E) ratio for Virax Biolabs Group Limited Ordinary Shares (VRAX) is 18.00 (data as of 2026-03-25).
Does Virax Biolabs Group Limited Ordinary Shares pay a dividend?
Dividend yield is not available in the current snapshot for Virax Biolabs Group Limited Ordinary Shares (VRAX). Check the MyAverix Finance app for the latest dividend data.
What sector is Virax Biolabs Group Limited Ordinary Shares in?
Virax Biolabs Group Limited Ordinary Shares (VRAX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is VRAX listed on?
VRAX is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.